Editorial board


Prof Emili Montserrat

Emeritus Professor of Medicine, Department of Hematology, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Editorial Board

Dr Akin Abayomi

Head of Division, Division of Haematology, Department of Pathology, Tygerberg Academic Hospital, Stellenbosch University/NHLS, Cape Town, South Africa; Principal Investigator, Global Emerging Pathogens Treatment (GET) Consortium; President, Federation of South African Societies of Pathology, South Africa.

Dr Emanuele Angelucci

Chair, Hematology and Transplant Unit, Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico, Genova, Italy.

Prof Michele Baccarani

Professor of Hematology (retired), Universities of Trieste, Udine, and Bologna, Italy; Chairman of the GIMEMA CML Working Party (formerly the Italian Cooperative Study Group on Chronic Myeloid Leukaemia) and Working Package 4 Chronic Myeloid Leukemia, European LeukemiaNet; Past-President of the the Italian Society of Experimental Haematology (1994-1995) and Italian Society of Haematology (2002-2003).

Dr Dominique Bonnet

Senior Group Leader, Francis Crick Institute; Honorary Professor, Imperial College; Honorary Professor, Division of BioScience, University College London; Honorary Professor, Division of Hemato/Oncology, Department of Medicine King’s College, London, UK.

Prof Loredana Bury

Section of Internal and Cadiovascular Medicina, Department of Medicine, University of Perugia, Perugia, Italy.

Prof Yves Chalandon

Head, Hematology Division; BMT Program, Geneva University Hospitals, Geneva, Switzerland.

Dr Smbat Daghbashyan

Head of Hematology, Yerevan State Medical University; Director of Hematology Center of the Republic of Armenia, Yerevan, Armenia; President of Armenian Hematology Association.

Dr Dimitar Efremov

Head, Molecular Hematology Unit, International Centre for Genetic Engineering & Biotechnology, Trieste, Italy.

Dr David Gómez Almaguer

Head, Hematology and Bone Marrow Transplantation Unit, Hospital Universitario Dr. Jose E. González UANL, Monterrey, México.

Dr Ciaren Graham

Centre for Biomedicine, School of Healthcare Science, Manchester Metropolitan University, Manchester, UK.

Prof Stefan Karlsson

Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University Hospital, Lund, Sweden.

Prof Sabri Kemahli

Professor of Pediatrics and Pediatric Hematology, Yeditepe University, Faculty of Medicine, Istanbul, Turkey; Alfaisal University College of Medicine, Riyadh, Saudi Arabia.

Prof Dr Karl-Anton Kreuzer

Clinic I for Internal Medicine, University Hospital Cologne, Cologne, Germany.

Prof Jeff Lipton

Leukemia and Allogeneic Stem Cell Transplant Programs, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

Dr Anca Roxana Lupu

Head, Hematology Department, Coltea Clinical Hospital; University of Medicine and Pharmacy Carol Davila, Bucharest, Romania; President of the Romanian Society of Hematology; Vice-president of the Romanian Society Haemostasis and Thrombosis.

Dr María-Victoria Mateos

Hematology Department, University Hospital of Salamanca, Salamanca, Spain.

Prof Ruben Mesa

Director, UT Health San Antonio Cancer Center: An NCI Designated Cancer Center; Mays Family Foundation Distinguished University Presidential Chair, San Antonio, Texas, USA.

Dr Ahmet Muzaffer Demir

Division of Hematology, Faculty of Medicine, Department of Medicine, Trakya University, Edirne, Turkey.

Dr Felipe Prósper

Director, Hematology and Cell Therapy, University Clinic of Navarra, Pamplona, Spain.